Rxivist logo

Prevailing homozygous deletion of interferon and defensin genes in human cancers

By Zhenqing Ye, Haidong Dong, Ying Li, Haojie Huang, Han Liang, Jean-Pierre A Kocher, Liguo Wang

Posted 19 Jan 2017
bioRxiv DOI: 10.1101/101741

Interferons and defensins are antimicrobial peptides that can also induce anti-tumor immunity. By analyzing the copy number profiles of 10759 patients across 31 cancer types, we found the homozygous deletions of interferon and defensin genes are prevailing in most human cancers, and that patients with these homozygous deletions exhibited significant reduced overall survival or disease-free survival. We further demonstrated that the homozygous deletion of interferon and defensin genes significantly impacted the expression of genes regulated by tumor necrosis factor (TNF) and IFNγ;. Our findings suggested a novel immune escape mechanism that disrupts the tumor cells′ ability to be recognized, and have implications for personalized immunotherapy.

Download data

  • Downloaded 643 times
  • Download rankings, all-time:
    • Site-wide: 34,405
    • In immunology: 911
  • Year to date:
    • Site-wide: 71,926
  • Since beginning of last month:
    • Site-wide: 42,844

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)